Skip to main content

Concert Pharmaceuticals, Inc.

CNCEDelisted Mar 6, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001367920

Concert Pharmaceuticals, Inc. was delisted on Mar 6, 2023; its insiders filed their last Form 4 on Mar 6, 2023; 85 institutions reported holding it in 13F filings for Q4 2022, worth $207.2M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Concert Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of CNCE: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders6152−9
Shares17.5M18.1M+673.1K (+3.9%)
Value$57.1M$57.1M+$2.93K (0.0%)

New holders (10)

Institutions that held Concert Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to CNCE in Q4 2021
InstitutionSharesValue% of portfolio
BVF Inc2,253,000$7.10M0.26%
NewEdge Wealth, LLC381,326$1.20M0.05%
Kensington Investment Counsel, LLC85,483$269.0K0.16%
Citadel Advisors LLC75,284$237.0K0.00%
Algert Global LLC19,300$61.0K0.01%
XTX Topco Ltd14,305$45.0K0.03%
Cubist Systematic Strategies, LLC12,254$39.0K0.00%
Two Sigma Securities, LLC10,921$34.0K0.01%
Dynamic Technology Lab Private Ltd10,536$33.0K0.00%
Royal Bank of Canada40$00.00%

Sold out (19)

Institutions that held Concert Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.